Assignee
SANOFI PASTEUR
FR·24 granted patents·28 pending applications·40 citations·filing 2004–2025
Top patents by PatentIndex Score
52 records- 0194US7641907B2Dengue serotype 1 attenuated strainSANOFI PASTEUR·Filed 2006·Granted Jan 5, 2010·16 cites·10 claims
- 0293US7641908B2Dengue serotype 2 attenuated strainSANOFI PASTEUR·Filed 2006·Granted Jan 5, 2010·17 cites·10 claims
- 0372US2023277655A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2022·Application pending·0 cites
- 0471US11690903B2Compositions for booster vaccination against dengueSANOFI PASTEUR·Filed 2018·Granted Jul 4, 2023·1 cites·22 claims
- 0571US2025019774A1Primers and probes for detecting mycobacteriaSANOFI PASTEUR·Filed 2024·Application pending·0 cites
- 0669US10144940B2Method for producing Haemophilus influenzae type B antigensSANOFI PASTEUR·Filed 2016·Granted Dec 4, 2018·2 cites·35 claims
- 0768US10118951B2Multimerization of recombinant protein by fusion to a sequence from lampreySANOFI PASTEUR·Filed 2015·Granted Nov 6, 2018·1 cites·22 claims
- 0868US9937252B2Induction of cross-reactive cellular response against rhinovirus antigensSANOFI PASTEUR·Filed 2014·Granted Apr 10, 2018·1 cites·15 claims
- 0966US9028839B2Stabilizing excipient for inactivated whole virus vaccineSANOFI PASTEUR·Filed 2013·Granted May 12, 2015·1 cites·23 claims
- 1066US2015031857A1Dengue serotype 2 attenuated strainSANOFI PASTEUR·Filed 2014·Application pending·0 cites
- 1165US11207403B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2020·Granted Dec 28, 2021·0 cites·13 claims
- 1264US11524069B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2018·Granted Dec 13, 2022·0 cites·20 claims
- 1364US11452772B2Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the sameSANOFI PASTEUR·Filed 2021·Granted Sep 27, 2022·0 cites·15 claims
- 1464US2025228933A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2025·Application pending·0 cites
- 1561US7507718B2Polymyxin B analogs for LPS detoxificationSANOFI PASTEUR·Filed 2006·Granted Mar 24, 2009·1 cites·77 claims
- 1661US2009104227A1Vaccine composition for the prevention of cmv infectionSANOFI PASTEUR·Filed 2008·Application pending·0 cites
- 1760US2023338504A1Compositions for Booster Vaccination Against DengueSANOFI PASTEUR·Filed 2023·Application pending·0 cites
- 1860US2007087009A1Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonistSANOFI PASTEUR·Filed 2004·Application pending·0 cites
- 1960US2025115881A1Modified vero cells and methods of using the same for virus productionSANOFI PASTEUR·Filed 2023·Application pending·0 cites
- 2058US7871807B2Method for producing the flu virusSANOFI PASTEUR·Filed 2008·Granted Jan 18, 2011·0 cites·19 claims
- 2158US2023366883A1Diagnostic TestsSANOFI PASTEUR·Filed 2023·Application pending·0 cites
- 2258US2023293447A1Cleavable lipidic compounds, compositions containing thereof, and uses thereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 2355US2010111990A1Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected WomenSANOFI PASTEUR·Filed 2008·Application pending·0 cites
- 2454US10577398B2Multimerization of recombinant protein by fusion to a sequence from lampreySANOFI PASTEUR·Filed 2018·Granted Mar 3, 2020·0 cites·20 claims
- 2554US2022328139A1Method for determining at a current time point a preservation state of one product and computer system for carrying out said methodSANOFI PASTEUR·Filed 2020·Application pending·0 cites
- 2653US2014178478A1Immuno-Adjuvant EmulsionSANOFI PASTEUR·Filed 2014·Application pending·0 cites
- 2752US2009203881A1Polymyxin B Analogs for LPS DetoxificationSANOFI PASTEUR·Filed 2009·Application pending·0 cites
- 2851US2025339506A1Compositions for use in treatment of chlamydiaSANOFI PASTEUR·Filed 2025·Application pending·0 cites
- 2950US9982240B2Production of infectious influenza virusesSANOFI PASTEUR·Filed 2013·Granted May 29, 2018·0 cites·15 claims
- 3050US2008107685A1Live Attenuated Dengue 3 Virus StrainsSANOFI PASTEUR·Filed 2007·Application pending·0 cites
- 3150US2023295097A1Lipidic compounds comprising at least one terminal radical of formula -nh-cx-a or -nh-cx-nh-a, compositions containing them and uses thereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 3249US11471521B2Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the sameSANOFI PASTEUR·Filed 2019·Granted Oct 18, 2022·0 cites·12 claims
- 3349US2010291192A1Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteriaSANOFI PASTEUR·Filed 2010·Application pending·0 cites
- 3449US2023398211A1Liposomes Containing TLR4 Agonist, Preparation and Uses ThereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 3547US10772946B2Immunogenic compositions against S. aureusSANOFI PASTEUR·Filed 2016·Granted Sep 15, 2020·0 cites·32 claims
- 3646US9556464B2Method for producing Haemophilus influenzae type B antigensSANOFI PASTEUR·Filed 2013·Granted Jan 31, 2017·0 cites·26 claims
- 3742US2019201517A1Vaccine CompositionsSANOFI PASTEUR·Filed 2018·Application pending·0 cites
- 3841US2006165717A1DCchol in newbornsSANOFI PASTEUR·Filed 2006·Application pending·0 cites
- 3941US2015196631A1Vaccine compositionsSANOFI PASTEUR·Filed 2013·Application pending·0 cites
- 4041US2010247557A1Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 AgonistSANOFI PASTEUR·Filed 2010·Application pending·0 cites
- 4140US10232029B2Compositions comprising N. meningitidis proteinsSANOFI PASTEUR·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 4240US2013028934A1Stabilizer and Vaccine Composition Comprising One or More Live Attenuated FlavivirusesSANOFI PASTEUR·Filed 2012·Application pending·0 cites
- 4339US2015265695A1Vaccine compositions for prevention against dengue virus infectionSANOFI PASTEUR·Filed 2013·Application pending·0 cites
- 4438US12515845B2Internal cardboard support for receiving pharmaceutical products, packaging and method for packagingSANOFI PASTEUR·Filed 2021·Granted Jan 6, 2026·0 cites·17 claims
- 4538US2015273035A1Vaccination against japanese encephalitis, measles, mumps and rubellaSANOFI PASTEUR·Filed 2013·Application pending·0 cites
- 4637US9938055B2Method of storing a vaccine containing an aluminum adjuvantSANOFI PASTEUR·Filed 2015·Granted Apr 10, 2018·0 cites·11 claims
- 4734US12343306B2Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plurality of such packaging units and method for producing such packaging unitSANOFI PASTEUR·Filed 2019·Granted Jul 1, 2025·0 cites·22 claims
- 4834US2018125961A1Neisseria meningitidis trypsin-like serine protease polypeptides and compositions thereofSANOFI PASTEUR·Filed 2015·Application pending·0 cites
- 4933US2018125960A1Meningitidis vaccines comprising subtilinasesSANOFI PASTEUR·Filed 2015·Application pending·0 cites
- 5032US10946087B2Vaccine compositions against dengue virus diseasesSANOFI PASTEUR·Filed 2015·Granted Mar 16, 2021·0 cites·27 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SANOFI PASTEUR files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →